T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortinet
FTNT
|
+$2.03B |
| 2 |
Rockwell Automation
ROK
|
+$1.44B |
| 3 |
Autodesk
ADSK
|
+$1.15B |
| 4 |
Citigroup
C
|
+$975M |
| 5 |
ConocoPhillips
COP
|
+$967M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.59B |
| 2 |
GE Aerospace
GE
|
+$1.78B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.38B |
| 4 |
Meta Platforms (Facebook)
META
|
+$1.08B |
| 5 |
Philip Morris
PM
|
+$1.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.21% |
| 2 | Healthcare | 15.42% |
| 3 | Financials | 10.99% |
| 4 | Consumer Discretionary | 10.39% |
| 5 | Communication Services | 8.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Golar LNG
GLNG
$5.21B
| $674K | ﹤0.01% |
27,990
+3,315
| +13% | +$73.8K |
|
2077
Fidelity MSCI Information Technology Index ETF
FTEC
$21.6B
| $671K | ﹤0.01% |
4,302
| – | – |
|
2078
Acco Brands
ACCO
$399M
| $667K | ﹤0.01% |
118,786
+3,811
| +3% | +$22.7K |
|
2079
AdaptHealth
AHCO
$760M
| $667K | ﹤0.01% |
57,874
+4,575
| +9% | +$38.9K |
|
2080
ImmunityBio
IBRX
$8.11B
| $667K | ﹤0.01% |
123,879
+4,533
| +4% | +$20.5K |
|
|
LADR
2081
Ladder Capital
LADR
$1.27B
| $667K | ﹤0.01% |
59,886
+4,063
| +7% | +$44.6K |
|
2082
BioCryst Pharmaceuticals
BCRX
$2.51B
| $665K | ﹤0.01% |
130,775
+17,091
| +15% | +$96.1K |
|
|
BDN
2083
Brandywine Realty Trust
BDN
$542M
| $664K | ﹤0.01% |
138,331
+6,721
| +5% | +$31.2K |
|
|
AGNT
2084
AGNT Inc
AGNT
$752M
| $663K | ﹤0.01% |
64,126
+2,845
| +5% | +$34.9K |
|
2085
Gorman-Rupp
GRC
$2.11B
| $659K | ﹤0.01% |
16,645
+980
| +6% | +$35K |
|
2086
American Vanguard Corp
AVD
$62.8M
| $658K | ﹤0.01% |
50,765
+715
| +1% | +$7.84K |
|
2087
Arcus Biosciences
RCUS
$3.67B
| $657K | ﹤0.01% |
34,764
+1,906
| +6% | +$33K |
|
2088
Shore Bancshares
SHBI
$799M
| $657K | ﹤0.01% |
57,086
+6,321
| +12% | +$75.8K |
|
2089
First Commonwealth Financial
FCF
$2.19B
| $656K | ﹤0.01% |
47,117
+3,676
| +8% | +$50.7K |
|
2090
Global E Online
GLBE
$7.09B
| $654K | ﹤0.01% |
17,985
+3,985
| +28% | +$148K |
|
|
KE
2091
Kimball Electronics
KE
$626M
| $651K | ﹤0.01% |
30,055
+889
| +3% | +$20.1K |
|
|
NVRO
2092
DELISTED
NEVRO CORP.
NVRO
| $651K | ﹤0.01% |
45,016
+7,004
| +18% | +$116K |
|
2093
Ameresco
AMRC
$1.47B
| $650K | ﹤0.01% |
26,931
+6,875
| +34% | +$154K |
|
2094
Lindsay Corp
LNN
$1.17B
| $643K | ﹤0.01% |
5,459
+401
| +8% | +$49.8K |
|
|
FARO
2095
DELISTED
Faro Technologies
FARO
| $642K | ﹤0.01% |
29,806
+897
| +3% | +$19.4K |
|
|
LBAI
2096
DELISTED
Lakeland Bancorp Inc
LBAI
| $642K | ﹤0.01% |
52,986
+10,433
| +25% | +$134K |
|
2097
Enovix
ENVX
$966M
| $641K | ﹤0.01% |
91,336
+5,749
| +7% | +$49.9K |
|
2098
Forward Air
FWRD
$682M
| $641K | ﹤0.01% |
20,604
+5,427
| +36% | +$227K |
|
|
SILK
2099
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $640K | ﹤0.01% |
34,905
+1,490
| +4% | +$23.6K |
|
|
EFC
2100
Ellington Financial
EFC
$1.76B
| $639K | ﹤0.01% |
54,094
+2,500
| +5% | +$30.1K |
|
Similar funds
T. Rowe Price Associates's Q1 2024 Portfolio in Review
As of Q1 2024, T. Rowe Price Associates held 3,021 positions worth $816B, up 9.6% from $744B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q1 2024 filing shows 108 new, 1,941 increased, 738 reduced and 64 closed positions. Its largest new stake was GE Vernova: 2,687,194 shares worth $367M. The largest sale was NVIDIA, an estimated $2.59B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q1 2024 buy was GE Vernova: 2,687,194 shares worth $367M.
- T. Rowe Price Associates added most to Fortinet in Q1 2024, an estimated $2.03B increase.
- T. Rowe Price Associates's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $2.59B.
- T. Rowe Price Associates fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $621M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $816B portfolio in Q1 2024.
- T. Rowe Price Associates opened 108 new positions and closed 64 in Q1 2024.
- T. Rowe Price Associates's portfolio value rose 9.6% quarter-over-quarter to $816B.
Based on T. Rowe Price Associates's 13F filing for Q1 2024, filed 15 May 2024.